Efficacy and Safety of Topical Mechanistic Target of Rapamycin Inhibitors for Facial Angiofibromas in Patients with Tuberous Sclerosis Complex: A Systematic Review and Network Meta-Analysis

Previous studies have suggested that the topical mechanistic target of rapamycin (mTOR) inhibitors may be effective in treating facial angiofibromas in patients with tuberous sclerosis complex (TSC). Various concentrations of topical sirolimus for TSC have been tested, but their comparative efficacy...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Yu-Ting Lin, Chia-Ling Yu, Yu-Kang Tu, Ching-Chi Chi
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	MDPI AG 2022-03-01
Saila:	Biomedicines
Gaiak:	angiofibroma mechanistic target of rapamycin (mTOR) network meta-analysis sirolimus systematic review tuberous sclerosis complex
Sarrera elektronikoa:	https://www.mdpi.com/2227-9059/10/4/826
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!